Hey Outlander2,
Always great to see you post. If only we could get a few more old favorites back as well !
You are spot on with the science. there hasn't been anything to raise any eyebrows, as yet that's been reported.
I'm one of the ignorant investors not grasping back a year ago, just how long trials take. However they don't do themselves any favours, in pushing data back continually. similarly, I've described Leslie as a game show host (continual smiles with only positive talk) with all the airtime she gives herself, we shouldn't need to go through annual reports in seeing data being pushed back to 2025. She knows it's what everyone wants, and had already bought herself six months back in May.
Mmany here are constantly visiting Credit Raising. That won't happen until the other CR happens- Complete Responses ! Whilst this stocks SP is now worth pittens, it's not in their interests'. I haven't seen anything where PH has been suggesting partnerships are being visited ( would love to see if anyone has something ), but their lack of concern over capital suggests something is in the making. That couldn't be far off being announced, as there's only so long they can treat investors like mushrooms ( hopefully there's been no BS, but they have kept us in the dark).
We've seen this stock go from $0.63c back in 2021, to where it is now -$0.038c. It started below where we are now to reach that high in less than 8 months. Should a few Complete responses drop, or any deal that creates revenue, IMU will see even greater growth than back then. That was all done on FOMO. Revenue or results would see the SP establish itself on its worth.
Other posters have been mentioning how aged data only saw a slight increase in OS (Overall Survival). Keep in mind these patients had failed at least two other treatments prior, and dosages have continued increasing. They were seen as extremely small dosages, couple that with seriously damaged immune systems, it's a wonder there's been any increse at all. With the Bile Duct study (has fast track FDA) because there's no reliable treatment as a standard of care, once this is approved - away we go ! It's also my understanding that Oncologist's can use our approved drugs on other cancers once approved, effectively opening the door.
I'm excited in seeing the trials expanded, as this only happens with great results.
Hopefully they can throw us investors a bone before Christmas. It's been so long since we've seen any light.
-GO IMU!
Not Financial Advice - Opinions Only - DYOR!
Expand
(20min delay)